文献速递临床试验与 GCP基础与转化研究

多发性硬化的神经心理学管理:评估一种居家自用的监督定制化认知康复方案(SEPIA):随机对照试验方案

Neuropsychological management of multiple sclerosis: evaluation of a supervised and customized cognitive rehabilitation program for self-used at home (SEPIA): protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2019-10-29

该随机对照试验方案拟纳入40例伴认知障碍的复发缓解型或继发进展型多发性硬化患者,随机分入为期8周的居家计算机化认知康复联合心理支持组或单纯心理支持对照组,主要评估生活质量(MUSIQOL问卷)在基线和干预后1周及25周的变化,次要结局包括自尊、认知、抑郁、焦虑、元认知、疲劳和睡眠质量。

要点

  • 试验纳入40例伴认知障碍的复发缓解型或继发进展型多发性硬化患者,每组20例。
  • 实验组接受8周居家计算机化认知康复(PRESCO®软件)联合心理支持,每周3次、每次45分钟。
  • 主要结局为MUSIQOL评估的生活质量,在基线、干预后1周和25周评估。

核心结论

  • 证据提示计算机化程序可能是多发性硬化患者认知康复的实践选择,但评估生活质量的研​​究匮乏。
  • 作者希望该创新方案能展示对患者日常生活随时间的获益,未来为伴认知障碍的多发性硬化患者及照护从业者提供更广泛的治疗选择。

研究设计与样本

  • 随机对照试验方案(SEPIA,NCT03471338),计划纳入40例伴认知障碍的复发缓解型或继发进展型多发性硬化患者,随机分入实验组或对照组。
  • 实验组接受为期连续8周的居家认知康复联合心理支持,认知康复基于HAPPYneuron©开发的PRESCO®软件计算机化认知练习,每周3次、每次45分钟,包含评估广泛认知域的短练习,并通过跟踪工具和监督指导实现个体化。
  • 对照组仅接受心理支持,内容涉及多发性硬化相关各种问题,如日常认知相关困难或情绪管理,以控制干预的非特异性元素。
  • 主要结局为MUSIQOL问卷评估的生活质量,在基线、居家干预后1周和25周评估;次要结局包括自尊、认知、抑郁、焦虑、元认知、疲劳和睡眠质量。
  • 根据预期MUSIQOL变化,每组需纳入20例患者(α风险5%,把握度80%)。

关键数值与推荐

  • 每组需纳入20例患者(α风险5%,把握度80%),共40例。
  • 实验组认知康复为每周3次、每次45分钟,连续8周。
  • 生活质量采用MUSIQOL问卷在基线、干预后1周和25周共评估3次。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 试验为回顾性注册(2018年4月25日)。
  • 证据提示计算机化程序可能是实践选择,但评估生活质量的研​​究匮乏。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cognitive and mood disorders negatively impact daily life in patients with multiple sclerosis (MS). Pharmacological treatments did not demonstrate any effect on cognition compared with cognitive rehabilitation (CR). However, if CR programs offer promising results on cognition, they are less consistent concerning mood and quality of life (QoL). In this context, we designed a randomized controlled trial to evaluate the efficacy of an innovative computerized CR program, conducted at home, on QoL. Secondary objectives will estimate the improvement, or the stabilization over time, of patients' cognitive performances and their emotional affects. METHODS: Forty MS patients (relapsing-remitting or secondary progressive forms) who have cognitive impairment will be recruited for the trial (called SEPIA-NCT03471338) and randomly assigned to either the experimental group or the control group. Patients randomly assigned in the experimental group will perform a home-based CR program with psychological support during eight consecutive weeks. CR will be based on computerized cognitive exercises from the PRESCO® software developed by HAPPYneuron©. Training sessions (three sessions of 45 min per week) will consist of short exercises evaluating a broad range of cognitive domains and will be personalized for each patient (tracking tool and supervised guidance). The control group, designed to control for non-specific elements of the intervention, will receive only psychological support consisting of various issues related to MS, such as everyday cognitive-related difficulties or management of emotions. QoL, assessed by the MUSIQOL (Multiple Sclerosis International Quality Of Life) questionnaire, will be evaluated three times (at baseline and after 1 week and 25 weeks after home-based intervention) as well as secondary outcomes measuring self-esteem, cognition, depression, anxiety, metacognition, fatigue, and sleep quality. Given the expected MUSIQOL variation, the inclusion of 20 patients per group (alpha risk 5% and power 80%) will be required. DISCUSSION: Evidence suggests that computerized programs may be a practice option for CR for people with MS, but there is a paucity of studies evaluating QoL. We hope that this innovative program will highlight such benefits over time in patients' daily life. In the future, such programs will allow a wider range of available therapeutic options for MS patients with cognitive impairment and for practitioners in charge of their care. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT03471338. Retrospectively registered on 25 April 2018. https://clinicaltrials.gov/ct2/show/NCT03471338?term=NCT03471338&cond=Multiple+Sclerosis&draw=2&rank=1 .

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Harand C, Daniel F, Mondou A, et al. Neuropsychological management of multiple sclerosis: evaluation of a supervised and customized cognitive rehabilitation program for self-used at home (SEPIA): protocol for a randomized controlled trial. Trials. 2019. PMID: 31665039. doi:10.1186/s13063-019-3715-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。